Dopamine Agonist News and Research

RSS
Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Teva to present abstracts on AZILECT at MDS meeting

Teva to present abstracts on AZILECT at MDS meeting

Promising studies for Parkinson's to be presented at 65th AAN meeting

Promising studies for Parkinson's to be presented at 65th AAN meeting

Nonmotor symptoms common in early-stage PD

Nonmotor symptoms common in early-stage PD

UCB’s Neupro now available in U.S. pharmacies

UCB’s Neupro now available in U.S. pharmacies

UCB receives FDA approval for Neupro to treat idiopathic Parkinson's, RLS

UCB receives FDA approval for Neupro to treat idiopathic Parkinson's, RLS

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

Parkinson's disease drugs may lead to impulse control disorders

Parkinson's disease drugs may lead to impulse control disorders

Dopamine agonists used in treatment of Parkinson's disease may lead to impulse control disorders

Dopamine agonists used in treatment of Parkinson's disease may lead to impulse control disorders

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

Santarus, VeroScience enter agreement to commercialize CYCLOSET drug for type 2 diabetes

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Pramipexole ER uptake to be inhibited by availability of generic version

Pramipexole ER uptake to be inhibited by availability of generic version

Brain mechanisms behind compulsive behaviors in Parkinson's disease patients

Brain mechanisms behind compulsive behaviors in Parkinson's disease patients

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

NuPathe and SurModics sign a drug delivery technology license agreement

NuPathe and SurModics sign a drug delivery technology license agreement

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Dopamine agonists trigger destructive behaviors

Dopamine agonists trigger destructive behaviors

Long-term effects of two common drugs for early Parkinson's similar

Long-term effects of two common drugs for early Parkinson's similar

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.